Anderson Hoagland & Co’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-32,694	Closed	-$2.39M	–	131
2023 Q3	$2.39M	Buy	32,694 +95	+0.3%	+$7.59K	0.32%	78
2023 Q2	$2.71M	Sell	32,599 -180	-0.5%	-$15.1K	0.35%	75
2023 Q1	$2.5M	Sell	32,779 -160	-0.5%	-$13.3K	0.36%	73
2022 Q4	$2.8M	Sell	32,939 -213	-0.6%	-$17.2K	0.41%	70
2022 Q3	$2.63M	Buy	33,152 +16,797	+103%	+$1.42M	0.42%	65
2022 Q2	$1.36M	Sell	16,355 -9,938	-38%	-$746K	0.21%	87
2022 Q1	$2.36M	Buy	26,293 +21	+0.1%	+$1.94K	0.3%	71
2021 Q4	$2.42M	Buy	26,272 +289	+1%	+$34.9K	0.32%	76
2021 Q3	$3.27M	Buy	25,983 +1,035	+4%	+$133K	0.42%	62
2021 Q2	$3.38M	Buy	24,948 +432	+2%	+$56.8K	0.43%	60
2021 Q1	$3.33M	Sell	24,516 -1,949	-7%	-$292K	0.47%	57
2020 Q4	$3.73M	Buy	+26,465	New	+$3.39M	0.59%	50